Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $66 | - | In Stock | |
| 5 mg | $158 | - | In Stock | |
| 10 mg | $243 | - | In Stock | |
| 25 mg | $522 | - | In Stock | |
| 50 mg | $868 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $179 | - | In Stock |
| Description | trans-Ned 19 is a nicotinic acid adenine dinucleotide phosphate (NAADP) antagonist and two-pore channel (TPC) blocker. It binds with high affinity to the NAADP receptor to inhibit NAADP-dependent lysosomal/endolysosomal calcium release without affecting IP3 or cADPR-mediated calcium signaling pathways. Functionally, trans-Ned 19 inhibits glucose-induced calcium oscillations in pancreatic islets and low histamine concentration-induced endothelium-dependent vasodilation, and reduces Ebola virus infection of host cells. In immunomodulation, NAADP signaling blockade by trans-Ned 19 promotes the conversion of mouse Th17 cells to regulatory T cells (Tregs) and shows protective effects in intestinal inflammation models. |
| In vitro | trans-Ned 19 (25–100 µM; 1 h) inhibits T-cell receptor (TCR)-stimulated Ca²⁺ signaling, cell activation, and proliferation in primary immature CD4⁺ T cells from C57BL/6N mice [1]. trans-Ned 19 (25–50 µM; 10 min) inhibits norepinephrine (HY-13715)-induced Ca²⁺ elevation in rat aortic smooth muscle cells in a concentration-dependent manner [2]. trans-Ned 19 (100 μM; 30 min) significantly increased the rate of spontaneous acrosome reaction in the acrosome reaction assay of permeabilized mouse sperm [3]. |
| In vivo | trans-Ned 19 (20 mg/kg; intraperitoneal injection; administered once 2 hours prior to the first injection of anti-CD3 mAb, followed by a second dose 48 hours later) reduced disease severity in a mouse model of anti-CD3 mAb-induced intestinal inflammation, as evidenced by reduced weight loss [1]. |
| Molecular Weight | 514.59 |
| Formula | C30H31FN4O3 |
| Cas No. | 1354235-96-3 |
| Smiles | C(O)(=O)[C@@H]1CC2=C([C@H](N1)C3=CC(CN4CCN(CC4)C5=C(F)C=CC=C5)=C(OC)C=C3)NC=6C2=CC=CC6 |
| Relative Density. | 1.316 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (155.46 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.